(Q44206631)

30 November 2017

title

Search for Australia-S.H. antigen and antibody after a Norwegian hepatitis outbreak (English)

1 reference

30 November 2017

0 references

K Berg

1

1 reference

30 November 2017

O D Vellar

series ordinal

2

1 reference

30 November 2017

H P Nesvold

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 May 1971

1 reference

30 November 2017

1 reference

30 November 2017

volume

1

1 reference

30 November 2017

issue

7707

1 reference

30 November 2017

page(s)

1015

1 reference

Australia Antigen in Chronic Hepatitis in Australia

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

Failure to detect an Antigen associated with Hepatitis in a Community Epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

Serum hepatitis through wound infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

Serum hepatitis among Swedish track finders. An epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

ACUTE VIRAL HEPATITIS IN NORWEGIAN TRACK-FINDERS. AN EPIDEMIOLOGICAL STUDY IN NORWAY 1962-63

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

Cholinergic-anticholinergic antagonism in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2871%2991408-5

7 January 2021

10.1016/S0140-6736(71)91408-5

Identifiers

DOI

1 reference

30 November 2017

1 reference